表紙:全ゲノムシーケンシングの世界市場:製品タイプ別、技術別、生物別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年
市場調査レポート
商品コード
1422067

全ゲノムシーケンシングの世界市場:製品タイプ別、技術別、生物別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年

Whole Genome Sequencing Market Assessment, By Product Type, By Technology, By Organism, By Application, By End-Users, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 230 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
全ゲノムシーケンシングの世界市場:製品タイプ別、技術別、生物別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年
出版日: 2024年02月07日
発行: Market Xcel - Markets and Data
ページ情報: 英文 230 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の全ゲノムシーケンシングの市場規模は、2023年に34億4,000万米ドルとなりました。同市場は、2024年から2031年の予測期間に19.31%のCAGRで拡大し、2031年には141億2,000万米ドルに達すると予測されています。ヘルスケア従事者ががんや糖尿病などの慢性疾患や遺伝性疾患を正確に診断・予測できるようになり、効率的な治療計画や疾患管理戦略の策定に役立つことが、市場成長の主な要因として作用しています。

全ゲノムシーケンシングは、慢性疾患の原因となる遺伝子変異を早期に検出する手段を提供します。全ゲノムシーケンシングは、嚢胞性線維症などのさまざまな慢性疾患やその他の遺伝子異常を高精度で診断するために使用できるため、この業界に対するニーズが高まっています。全ゲノムシーケンシング製品は、医薬品開発、農業研究、法医学などさまざまなプロジェクトに取り組む遺伝子研究者の増加により需要が高まっています。この業界は、科学研究開発のための政府資金や技術的躍進の結果、大きく成長すると予想されています。しかし、製品に関連する高コスト、熟練した専門家の不足、複雑なデータの解釈などは、世界の全ゲノムシーケンシング市場の成長を妨げる障害となっています。

遺伝子異常や慢性疾患の発生率の増加は、全ゲノムシーケンシング市場を大きく牽引しています。がん、心血管疾患、その他の疾患などの慢性疾患の発生率と有病率の上昇が、全ゲノムシーケンシングに基づく診断の必要性を煽っています。多くの疾患の診断と治療は全ゲノムシーケンシングによって大いに助けられるため、関連製品とサービスの需要が高まっています。全ゲノムシーケンシング技術は、特定の疾患指標を特定し、治療に対する個人の反応を予測する能力により、ますます普及しています。

当レポートでは、世界の全ゲノムシーケンシング市場について調査し、市場の概要とともに、製品タイプ別、技術別、生物別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の全ゲノムシーケンシング市場の見通し、2017年~2031年

  • 市場規模と予測
  • 製品タイプ別
  • 技術別
  • 生物別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 企業別市場シェア(%)、2023年

第5章 世界の全ゲノムシーケンシング市場、2017年~2031年

  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸出入分析- 量と金額
  • サプライ/バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Illumina, Inc.
  • Thermo-Fischer scientific
  • BGI genomics
  • Agilent Technologies Inc.
  • 10X Genomics
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • PerkinElmer Inc.
  • Myriad Genetics Inc.

第14章 戦略的提言

第15章 お問合せと免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 6. Global Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 8. Global Whole Genome Sequencing Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 11. North America Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 12. North America Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 13. North America Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 14. North America Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 16. North America Whole Genome Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 19. United States Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 20. United States Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 21. United States Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 22. United States Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 24. Canada Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 26. Canada Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 27. Canada Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 28. Canada Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 29. Canada Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 31. Mexico Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 33. Mexico Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 34. Mexico Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 35. Mexico Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 36. Mexico Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 38. Europe Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 40. Europe Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 41. Europe Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 42. Europe Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 43. Europe Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 45. Europe Whole Genome Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. Germany Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 49. Germany Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 50. Germany Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 51. Germany Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 53. France Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 55. France Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 56. France Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 57. France Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 58. France Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 59. France Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 60. Italy Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 62. Italy Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 63. Italy Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 64. Italy Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 65. Italy Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 67. United Kingdom Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 69. United Kingdom Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 70. United Kingdom Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 71. United Kingdom Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 72. United Kingdom Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 74. Russia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 76. Russia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Russia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 78. Russia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 79. Russia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 80. Russia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 81. Netherlands Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 83. Netherlands Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 84. Netherlands Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 85. Netherlands Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 86. Netherlands Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 87. Netherlands Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 88. Spain Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Spain Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 91. Spain Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 92. Spain Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 93. Spain Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 94. Spain Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 95. Turkey Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 97. Turkey Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Turkey Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 99. Turkey Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 100. Turkey Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 101. Turkey Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 102. Poland Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 104. Poland Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 105. Poland Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 106. Poland Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 107. Poland Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 108. Poland Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 109. South America Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 111. South America Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 112. South America Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 113. South America Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 114. South America Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 115. South America Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 116. South America Whole Genome Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 119. Brazil Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 120. Brazil Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 121. Brazil Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 122. Brazil Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 123. Brazil Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 124. Argentina Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 126. Argentina Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 127. Argentina Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 128. Argentina Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 129. Argentina Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 130. Argentina Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 131. Asia-Pacific Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 133. Asia-Pacific Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Asia-Pacific Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 135. Asia-Pacific Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 136. Asia-Pacific Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 137. Asia- Pacific Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 138. Asia-Pacific Whole Genome Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 139. India Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 141. India Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 142. India Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 143. India Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 144. India Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 145. India Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 146. China Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 148. China Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 149. China Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 150. China Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 151. China Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 152. China Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 153. Japan Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 155. Japan Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 156. Japan Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 157. Japan Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 158. Japan Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 159. Japan Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 160. Australia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 162. Australia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 163. Australia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 164. Australia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 165. Australia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 166. Australia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 167. Vietnam Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 169. Vietnam Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 170. Vietnam Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 171. Vietnam Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 172. Vietnam Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 173. Vietnam Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 174. South Korea Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 176. South Korea Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 177. South Korea Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 178. South Korea Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 179. South Korea Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 180. South Korea Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 181. Indonesia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. Indonesia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 184. Indonesia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 185. Indonesia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 186. Indonesia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 187. Indonesia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 188. Philippines Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 190. Philippines Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 191. Philippines Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 192. Philippines Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 193. Philippines Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 194. Philippines Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 195. Middle East & Africa Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 197. Middle East & Africa Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 198. Middle East & Africa Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 199. Middle East & Africa Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 200. Middle East & Africa Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 201. Middle East & Africa Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 202. Middle East & Africa Whole Genome Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 205. Saudi Arabia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 206. Saudi Arabia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 207. Saudi Arabia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 208. Saudi Arabia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 209. Saudi Arabia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 210. UAE Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 212. UAE Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 213. UAE Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 214. UAE Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 215. UAE Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 216. UAE Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 217. South Africa Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 219. South Africa Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 220. South Africa Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 221. South Africa Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F
  • Figure 222. South Africa Whole Genome Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 223. South Africa Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 224. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Organism Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX10932

Global whole genome sequencing market size was valued at USD 3.44 billion in 2023 and is expected to reach USD 14.12 billion in 2031, with a CAGR of 19.31% for the forecast period between 2024 and 2031F. The ability of healthcare practitioners to precisely diagnose and predict chronic and genetic diseases, such as cancers and diabetes, which can help in the development of efficient treatment plans and disease management strategies, is acting as a major driver for the market growth.

Whole genome sequencing provides an early means of detecting genetic mutations that cause chronic disease. There is an increasing need for this industry since whole genome sequencing can be used to diagnose various chronic diseases and other genetic abnormalities, such as cystic fibrosis with high precision. Whole genome sequencing products are high in demand due to the growing number of genetic researchers working on various projects such as medication development, agricultural research, and forensics. The industry is anticipated to grow significantly as a result of government funding for scientific research and development as well as technological breakthroughs. However, the high cost associated with products, the lack of highly skilled professionals, and the interpretation of complicated data are some of the hindrances that can hamper the growth of the global whole genome sequencing market.

In March 2023, Illumina Inc. announced the launch of its first product based on its novel Illumina Complete Long Read technology. Illumina Inc. is a global provider of products used in DNA sequencing and array-based technologies. Illumina Complete Long Read Prep, Human is a high-performance, long-read, human whole-genome sequencing (WGS) assay that is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. Illumina Complete Long Reads offers long and short-read sequencing in the same instrument for the first time and enable a simpler workflow as compared to other long-read offerings.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The rising incidence of genetic abnormalities and chronic diseases significantly drives the market for whole genome sequencing. The rising incidence and prevalence of chronic illnesses such as cancer, cardiovascular diseases, and other conditions is fueling the need for whole genome sequencing-based diagnosis. The diagnosis and treatment of many disorders are greatly aided by whole genome sequencing, which has increased demand for related products and services. Whole genome sequencing techniques are becoming increasingly popular due to their ability to identify specific disease indicators and predict individual responses to therapies.

According to a factsheet updated by WHO in September 2023, noncommunicable diseases (NCDs) are responsible for killing 41 million people each year, equivalent to 74% of all deaths globally. Around 17 million people die from NCDs before the age of 70 years; 86% of these premature deaths occur in low- and middle-income countries. Cardiovascular diseases (CVDs) account for most NCD deaths, (17.9 million people annually), followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Growing Research and Development

The global whole genome sequencing market is positively impacted by increasing research and development surrounding genome exploration and its various benefits applications. Over the past few decades, the human genome projects have significantly contributed to the growing body of research concerning genome explorations. The market is anticipated to rise significantly in collaboration with the growing acceptance and application of NGS and Sanger technology in institutional and academic research projects.

For instance, in November 2023, UK Biobank Limited released the world's largest-by-far single set of sequencing data by investing EUR 200 million and conducted continuous research for five years into the public domain. The development of innovative diagnostics, therapies, and cures is expected to be fueled by this data. Researchers across the globe can access the data through a secure database that exclusively holds de-identified data.

Sanger Sequencing is Expected to Dominate During Forecast Period

For precise identification of single nucleotide mutations and minor insertions/deletions, Sanger sequencing is regarded as the gold standard. Sanger sequencing is preferred over other sequencing techniques due to its precision and accuracy. The segment is anticipated to lead the whole genome sequencing market's technology for the duration of the forecasted period due to the growing usage of Sanger sequencing. Numerous industry participants are committed to growing their businesses and offering more fast and accurate whole genome sequencing services.

In October 2023, Wellcome Sanger Institute announced the launch of 'Generative and Synthetic Genomics Program' to enhance research efforts on the 'Human Genetics' and 'Tree of Life' programs. By producing vast volumes of genomic data to feed into computer models will anticipate their consequences, such as the influence of mutations on disease, it seeks to bring together computational and experimental scientists to understand and forecast the impacts of editing DNA. Additionally, the researchers are expected to create tools for writing and editing genomes.

North America is Expected to Dominate the Market

North America is anticipated to dominate the market with the highest value share due to of its significant investment in R&D, technical breakthroughs made by major companies, and highly developed healthcare infrastructure in North American nations like the United States and Canada. Initiatives by the government are expected to expedite medication development process and cancer treatment, contributing to the market growth. In May 2023, The National Institutes of Health (NIH) launched a new program called Common Fund's Somatic Mosaicism Across Human Tissues (SMaHT) Network worth USD 140 million to explore knowledge about genetic variation in normal human cells and tissues.

Key Players Landscape and Outlook

Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using various strategies. Companies are expanding the range of products they offer to gain market share. Industry participants are using a variety of growth methods, including collaborations, mergers and acquisitions, product launches, and the development of new goods, to bolster their positions in the market.

In July 2023, MedGenome announced the acquisition of Illumina's NovaSeq X Plus. MedGenome is a leading global genomic diagnostic and research services organization in South Asia. The acquisition makes MedGenome the first to offer advanced genomics services using Illumina's NovaSeq X Plus in South Asia. Through the acquisition, the company anticipates cutting down the reagent cost of human whole genome sequencing to USD 200. MedGenome announced the launch of KaryoSeq (or Karyotype Sequencing), which is an innovative whole genome sequencing to diagnose prenatal and newborn conditions.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Whole Genome Sequencing Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Consumables
    • 4.2.2. Instruments
    • 4.2.3. Services
  • 4.3. By Technology
    • 4.3.1. Sanger Sequencing
    • 4.3.2. Next-Generation Sequencing
    • 4.3.3. Polymerase Chain Reaction
    • 4.3.4. Other Sequencing Technologies
  • 4.4. By Organism
    • 4.4.1. Humans
    • 4.4.2. Plants
    • 4.4.3. Animals
    • 4.4.4. Microbes
  • 4.5. By Application
    • 4.5.1. Diagnostic Applications
    • 4.5.2. Personalized Medicine
    • 4.5.3. Research Applications
      • 4.5.3.1. Forensics
      • 4.5.3.2. Agriculture
      • 4.5.3.3. Drug Development
      • 4.5.3.4. Others
  • 4.6. By End-users
    • 1.1.1. Hospitals and Healthcare Organizations
    • 1.1.2. Academics and Research Institutions
    • 1.1.3. Pharmaceutical and Biotechnology Companies
    • 1.1.4. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. Asia Pacific
    • 4.7.4. South America
    • 4.7.5. Middle East & Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Whole Genome Sequencing Market, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Consumables
      • 5.1.2.2. Instruments
      • 5.1.2.3. Services
    • 5.1.3. By Technology
      • 5.1.3.1. Sanger Sequencing
      • 5.1.3.2. Next-Generation Sequencing
      • 5.1.3.3. Polymerase Chain Reaction
      • 5.1.3.4. Other Sequencing Technologies
    • 5.1.4. By Organism
      • 5.1.4.1. Humans
      • 5.1.4.2. Plants
      • 5.1.4.3. Animals
      • 5.1.4.4. Microbes
    • 5.1.5. By Application
      • 5.1.5.1. Diagnostic Applications
      • 5.1.5.2. Personalized Medicine
      • 5.1.5.3. Research Applications
      • 5.1.5.3.1. Forensics
      • 5.1.5.3.2. Agriculture
      • 5.1.5.3.3. Drug Development
      • 5.1.5.3.4. Others
    • 5.1.6. By End-users
      • 5.1.6.1. Hospitals and Healthcare Organizations
      • 5.1.6.2. Academics and Research Institutions
      • 5.1.6.3. Pharmaceutical and Biotechnology Companies
      • 5.1.6.4. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
      • 5.1.7.1.1. By Value
      • 5.1.7.1.2. By Volume
      • 5.1.7.2. By Product Type
      • 5.1.7.2.1. Consumables
      • 5.1.7.2.2. Instruments
      • 5.1.7.2.3. Services
      • 5.1.7.3. By Technology
      • 5.1.7.3.1. Sanger Sequencing
      • 5.1.7.3.2. Next-Generation Sequencing
      • 5.1.7.3.3. Polymerase Chain Reaction
      • 5.1.7.3.4. Other Sequencing Technologies
      • 5.1.7.4. By Organism
      • 5.1.7.4.1. Humans
      • 5.1.7.4.2. Plants
      • 5.1.7.4.3. Animals
      • 5.1.7.4.4. Microbes
      • 5.1.7.5. By Application
      • 5.1.7.5.1. Diagnostic Applications
      • 5.1.7.5.2. Personalized Medicine
      • 5.1.7.5.3. Research Applications
      • 5.1.7.5.3.1. Forensics
      • 5.1.7.5.3.2. Agriculture
      • 5.1.7.5.3.3. Drug Development
      • 5.1.7.5.3.4. Others
      • 5.1.7.6. By End-users
      • 5.1.7.6.1. Hospitals and Healthcare Organizations
      • 5.1.7.6.2. Academics and Research Institutions
      • 5.1.7.6.3. Pharmaceutical and Biotechnology Companies
      • 5.1.7.6.4. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Technology
  • 6.3. By Organism
  • 6.4. By Application
  • 6.5. By End-users
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis - Volume and Value
  • 7.3. Supply/Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Illumina, Inc.,
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Thermo-Fischer scientific
  • 13.3. BGI genomics
  • 13.4. Agilent Technologies Inc.
  • 13.5. 10X Genomics
  • 13.6. QIAGEN
  • 13.7. F. Hoffmann-La Roche Ltd
  • 13.8. Merck KGaA
  • 13.9. PerkinElmer Inc.
  • 13.10. Myriad Genetics Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer